Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
With the help of machine learning, researchers were able to train a computer to analyze breast cancer images and classify tumors accurately, according to a study published in NPJ Breast Cancer.
After receiving FDA clearance for AI software that can detect brain bleeds from CT images, MaxQ AI has announced a deal to integrate the software with medical imaging platforms.
In an interview with AI in Healthcare, JingJia Liu, chief executive officer at Wision AI, discussed the company's new machine-learning algorithm for polyp detection, what’s next and the impact of AI products in the medical industry.
A deep-learning system (DLS) designed by Google researchers outperformed several top general pathologists when grading prostate cancer on a standard grade, according to newly-published research.
An AI-based network outperformed several dermatologists while analyzing skin lesions for cancer, suggesting the technology could be a helpful tool for physicians regardless of their experience, according to a recent study.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.